|
|
Volumn , Issue , 2009, Pages 578-586
|
|
Novel therapies for relapsed myeloma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AKT1 PROTEIN, HUMAN;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
BENDAMUSTINE;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
CARFILZOMIB;
CHLORMETHINE DERIVATIVE;
DRUG DERIVATIVE;
HEAT SHOCK PROTEIN;
HISTONE DEACETYLASE INHIBITOR;
IMMUNOLOGIC FACTOR;
NEW DRUG;
OLIGOPEPTIDE;
POMALIDOMIDE;
PROTEASOME;
PROTEIN KINASE B;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
THALIDOMIDE;
TUMOR PROTEIN;
ANIMAL;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG SCREENING;
HUMAN;
MOUSE;
MULTIPLE MYELOMA;
REVIEW;
SALVAGE THERAPY;
STATISTICS;
TRANSGENIC MOUSE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CLINICAL TRIALS AS TOPIC;
DRUG ADMINISTRATION SCHEDULE;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUGS, INVESTIGATIONAL;
HEAT-SHOCK PROTEINS;
HISTONE DEACETYLASE INHIBITORS;
HUMANS;
IMMUNOLOGIC FACTORS;
MICE;
MICE, TRANSGENIC;
MULTIPLE MYELOMA;
NEOPLASM PROTEINS;
NITROGEN MUSTARD COMPOUNDS;
OLIGOPEPTIDES;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTO-ONCOGENE PROTEINS C-AKT;
PYRAZINES;
SALVAGE THERAPY;
THALIDOMIDE;
|
|
EID: 77949475477
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.578 Document Type: Review |
|
Times cited : (23)
|
|
References (59)
|
